Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan T Stern

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
Journal for Immunotherapy of Cancer|March 22, 2025
PLS-α-GalCer: a novel targeted glycolipid therapy for solid tumorsJulian Burks, Shweta Tiwary, David M Stevens, et al.
Toxicology Reports|April 25, 2025
Preclinical SC and IV repeat-dose toxicology of a cowpea mosaic virus - A cancer immunotherapy candidateStephan T Stern, Jessica Fernanda Affonso de Oliveira, Jamie Gatus, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 14, 2013
Prediction of nanoparticle prodrug metabolism by pharmacokinetic modeling of biliary excretionStephan T Stern, Peng Zou, Sarah Skoczen, et al.
Toxicology and Applied Pharmacology|August 18, 2010
Fullerenol cytotoxicity in kidney cells is associated with cytoskeleton disruption, autophagic vacuole accumulation, and mitochondrial dysfunctionDenise N Johnson-Lyles, Kimberly Peifley, Stephen Lockett, et al.
Molecular Cancer Therapeutics|April 3, 2025
Target-Specific Locked Nucleic Acid Gapmer Decreases Growth and Metastases of Pancreatic CancerJill P Smith, Narayan Shivapurkar, Wenqiang Chen, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 14, 2010
Translational considerations for cancer nanomedicineStephan T Stern, Jennifer B Hall, Lee L Yu, et al.
International Journal of Molecular Sciences|January 8, 2023
Target-Specific Nanoparticle Polyplex Down-Regulates Mutant <i>Kras</i> to Prevent Pancreatic Carcinogenesis and Halt Tumor ProgressionJill P Smith, Wenqiang Chen, Narayan Shivapurkar, et al.
Integrative Biology : Quantitative Biosciences From Nano to Macro|July 10, 2012
Common pitfalls in nanotechnology: lessons learned from NCI's Nanotechnology Characterization LaboratoryRachael M Crist, Jennifer Hall Grossman, Anil K Patri, et al.
Cellular and Molecular Gastroenterology and Hepatology|June 22, 2018
Cholecystokinin Receptor-Targeted Polyplex Nanoparticle Inhibits Growth and Metastasis of Pancreatic CancerJulian Burks, Sandeep Nadella, Abdullah Mahmud, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2010
A novel nanoparticulate formulation of arsenic trioxide with enhanced therapeutic efficacy in a murine model of breast cancerRichard W Ahn, Feng Chen, Haimei Chen, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Journal for Immunotherapy of Cancer|March 22, 2025
PLS-α-GalCer: a novel targeted glycolipid therapy for solid tumorsJulian Burks, Shweta Tiwary, David M Stevens, et al.
Toxicology Reports|April 25, 2025
Preclinical SC and IV repeat-dose toxicology of a cowpea mosaic virus - A cancer immunotherapy candidateStephan T Stern, Jessica Fernanda Affonso de Oliveira, Jamie Gatus, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 14, 2013
Prediction of nanoparticle prodrug metabolism by pharmacokinetic modeling of biliary excretionStephan T Stern, Peng Zou, Sarah Skoczen, et al.
Toxicology and Applied Pharmacology|August 18, 2010
Fullerenol cytotoxicity in kidney cells is associated with cytoskeleton disruption, autophagic vacuole accumulation, and mitochondrial dysfunctionDenise N Johnson-Lyles, Kimberly Peifley, Stephen Lockett, et al.
Molecular Cancer Therapeutics|April 3, 2025
Target-Specific Locked Nucleic Acid Gapmer Decreases Growth and Metastases of Pancreatic CancerJill P Smith, Narayan Shivapurkar, Wenqiang Chen, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 14, 2010
Translational considerations for cancer nanomedicineStephan T Stern, Jennifer B Hall, Lee L Yu, et al.
International Journal of Molecular Sciences|January 8, 2023
Target-Specific Nanoparticle Polyplex Down-Regulates Mutant <i>Kras</i> to Prevent Pancreatic Carcinogenesis and Halt Tumor ProgressionJill P Smith, Wenqiang Chen, Narayan Shivapurkar, et al.
Integrative Biology : Quantitative Biosciences From Nano to Macro|July 10, 2012
Common pitfalls in nanotechnology: lessons learned from NCI's Nanotechnology Characterization LaboratoryRachael M Crist, Jennifer Hall Grossman, Anil K Patri, et al.
Cellular and Molecular Gastroenterology and Hepatology|June 22, 2018
Cholecystokinin Receptor-Targeted Polyplex Nanoparticle Inhibits Growth and Metastasis of Pancreatic CancerJulian Burks, Sandeep Nadella, Abdullah Mahmud, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2010
A novel nanoparticulate formulation of arsenic trioxide with enhanced therapeutic efficacy in a murine model of breast cancerRichard W Ahn, Feng Chen, Haimei Chen, et al.
Pageof 6